Cargando…
Contrast enhanced transesophageal echocardiography in patients with atrial fibrillation referred to electrical cardioversion improves atrial thrombus detection and may reduce associated thromboembolic events
AIMS: Transesophageal echocardiography (TEE) is the gold standard for the detection of thrombi in patients with atrial fibrillation (AF) before undergoing early electrical cardioversion (CV). However, TEE generates inconclusive results in a considerable number of patients. This study investigated th...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554518/ https://www.ncbi.nlm.nih.gov/pubmed/23295101 http://dx.doi.org/10.1186/1476-7120-11-1 |
_version_ | 1782256909502382080 |
---|---|
author | Jung, Philip H Mueller, Marisa Schuhmann, Christoph Eickhoff, Madeleine Schneider, Philip Seemueller, Gueler Dutton, Raphael Rieber, Johannes Kääb, Stefan Sohn, Hae-Young |
author_facet | Jung, Philip H Mueller, Marisa Schuhmann, Christoph Eickhoff, Madeleine Schneider, Philip Seemueller, Gueler Dutton, Raphael Rieber, Johannes Kääb, Stefan Sohn, Hae-Young |
author_sort | Jung, Philip H |
collection | PubMed |
description | AIMS: Transesophageal echocardiography (TEE) is the gold standard for the detection of thrombi in patients with atrial fibrillation (AF) before undergoing early electrical cardioversion (CV). However, TEE generates inconclusive results in a considerable number of patients. This study investigated the influence of contrast enhancement on interpretability of TEE for the detection of left atrial (LA) thrombi compared to conventional TEE and assessed, whether there are differences in the rate of thromboembolic events after electrical cardioversion. METHODS: Of 180 patients with AF (51 females, 65.2±13 years) who were referred to CV, 90 were examined with native imaging and contrast enhancement within the same examination (group 1), and 90 were examined with native TEE alone and served as control (group 2). Cineloops of the multiplane examination of the LA and LA appendage (LAA) were stored digitally before and, in group 1, after intravenous bolus application of a transpulmonary contrast agent. Images of group 1 were assessed offline and the diagnosis of LA thrombi was made semi-quantitatively: 1= thrombus present; 2=inconclusive result; 3=no thrombus. The presence of spontaneous echocontrast (SEC) was registered and flow velocity in the LA appendage (LAA-flow) was measured. All patients in whom CV was performed were followed up for 1 year or until relapse of AF. CV related adverse events were defined as any thromboembolic event within 1 week after CV. RESULTS: No serious adverse events occurred during TEE and contrast enhanced imaging. In group 1 atrial thrombi were diagnosed in 14 (15.6%) during native and in 10 (11.1%) patients during contrast enhanced imaging (p<0.001). Of the 10 patients with thrombi in the contrast TEE group, 7 revealed a decreased LAA-flow (≤0,3m/s) and 8 showed moderate or marked SEC. Uncertain results were significantly more common during native imaging than with contrast enhanced TEE (16 vs. 5 patients, p<0.01). Thrombi could definitely be excluded in 60 (66.7%) during conventional and in 75 patients (83.3%) during contrast enhanced TEE (p<0.01). CV was performed subsequently after exclusion of thrombi and at the discretion of the investigator. In group 1, 74 patients (82.2%) were cardioverted and no patient suffered a CV related complication (p=0.084). In group 2, 76 patients (84.4%) underwent CV, of whom 3 suffered a thromboembolic complication after CV (2 strokes, 1 peripheral embolism). CONCLUSION: In patients with AF planned for CV contrast enhancement renders TEE images more interpretable, facilitates the exclusion of atrial thrombi and may reduce the rate of embolic adverse events. |
format | Online Article Text |
id | pubmed-3554518 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35545182013-01-29 Contrast enhanced transesophageal echocardiography in patients with atrial fibrillation referred to electrical cardioversion improves atrial thrombus detection and may reduce associated thromboembolic events Jung, Philip H Mueller, Marisa Schuhmann, Christoph Eickhoff, Madeleine Schneider, Philip Seemueller, Gueler Dutton, Raphael Rieber, Johannes Kääb, Stefan Sohn, Hae-Young Cardiovasc Ultrasound Research AIMS: Transesophageal echocardiography (TEE) is the gold standard for the detection of thrombi in patients with atrial fibrillation (AF) before undergoing early electrical cardioversion (CV). However, TEE generates inconclusive results in a considerable number of patients. This study investigated the influence of contrast enhancement on interpretability of TEE for the detection of left atrial (LA) thrombi compared to conventional TEE and assessed, whether there are differences in the rate of thromboembolic events after electrical cardioversion. METHODS: Of 180 patients with AF (51 females, 65.2±13 years) who were referred to CV, 90 were examined with native imaging and contrast enhancement within the same examination (group 1), and 90 were examined with native TEE alone and served as control (group 2). Cineloops of the multiplane examination of the LA and LA appendage (LAA) were stored digitally before and, in group 1, after intravenous bolus application of a transpulmonary contrast agent. Images of group 1 were assessed offline and the diagnosis of LA thrombi was made semi-quantitatively: 1= thrombus present; 2=inconclusive result; 3=no thrombus. The presence of spontaneous echocontrast (SEC) was registered and flow velocity in the LA appendage (LAA-flow) was measured. All patients in whom CV was performed were followed up for 1 year or until relapse of AF. CV related adverse events were defined as any thromboembolic event within 1 week after CV. RESULTS: No serious adverse events occurred during TEE and contrast enhanced imaging. In group 1 atrial thrombi were diagnosed in 14 (15.6%) during native and in 10 (11.1%) patients during contrast enhanced imaging (p<0.001). Of the 10 patients with thrombi in the contrast TEE group, 7 revealed a decreased LAA-flow (≤0,3m/s) and 8 showed moderate or marked SEC. Uncertain results were significantly more common during native imaging than with contrast enhanced TEE (16 vs. 5 patients, p<0.01). Thrombi could definitely be excluded in 60 (66.7%) during conventional and in 75 patients (83.3%) during contrast enhanced TEE (p<0.01). CV was performed subsequently after exclusion of thrombi and at the discretion of the investigator. In group 1, 74 patients (82.2%) were cardioverted and no patient suffered a CV related complication (p=0.084). In group 2, 76 patients (84.4%) underwent CV, of whom 3 suffered a thromboembolic complication after CV (2 strokes, 1 peripheral embolism). CONCLUSION: In patients with AF planned for CV contrast enhancement renders TEE images more interpretable, facilitates the exclusion of atrial thrombi and may reduce the rate of embolic adverse events. BioMed Central 2013-01-07 /pmc/articles/PMC3554518/ /pubmed/23295101 http://dx.doi.org/10.1186/1476-7120-11-1 Text en Copyright ©2013 Jung et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Jung, Philip H Mueller, Marisa Schuhmann, Christoph Eickhoff, Madeleine Schneider, Philip Seemueller, Gueler Dutton, Raphael Rieber, Johannes Kääb, Stefan Sohn, Hae-Young Contrast enhanced transesophageal echocardiography in patients with atrial fibrillation referred to electrical cardioversion improves atrial thrombus detection and may reduce associated thromboembolic events |
title | Contrast enhanced transesophageal echocardiography in patients with atrial fibrillation referred to electrical cardioversion improves atrial thrombus detection and may reduce associated thromboembolic events |
title_full | Contrast enhanced transesophageal echocardiography in patients with atrial fibrillation referred to electrical cardioversion improves atrial thrombus detection and may reduce associated thromboembolic events |
title_fullStr | Contrast enhanced transesophageal echocardiography in patients with atrial fibrillation referred to electrical cardioversion improves atrial thrombus detection and may reduce associated thromboembolic events |
title_full_unstemmed | Contrast enhanced transesophageal echocardiography in patients with atrial fibrillation referred to electrical cardioversion improves atrial thrombus detection and may reduce associated thromboembolic events |
title_short | Contrast enhanced transesophageal echocardiography in patients with atrial fibrillation referred to electrical cardioversion improves atrial thrombus detection and may reduce associated thromboembolic events |
title_sort | contrast enhanced transesophageal echocardiography in patients with atrial fibrillation referred to electrical cardioversion improves atrial thrombus detection and may reduce associated thromboembolic events |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554518/ https://www.ncbi.nlm.nih.gov/pubmed/23295101 http://dx.doi.org/10.1186/1476-7120-11-1 |
work_keys_str_mv | AT jungphiliph contrastenhancedtransesophagealechocardiographyinpatientswithatrialfibrillationreferredtoelectricalcardioversionimprovesatrialthrombusdetectionandmayreduceassociatedthromboembolicevents AT muellermarisa contrastenhancedtransesophagealechocardiographyinpatientswithatrialfibrillationreferredtoelectricalcardioversionimprovesatrialthrombusdetectionandmayreduceassociatedthromboembolicevents AT schuhmannchristoph contrastenhancedtransesophagealechocardiographyinpatientswithatrialfibrillationreferredtoelectricalcardioversionimprovesatrialthrombusdetectionandmayreduceassociatedthromboembolicevents AT eickhoffmadeleine contrastenhancedtransesophagealechocardiographyinpatientswithatrialfibrillationreferredtoelectricalcardioversionimprovesatrialthrombusdetectionandmayreduceassociatedthromboembolicevents AT schneiderphilip contrastenhancedtransesophagealechocardiographyinpatientswithatrialfibrillationreferredtoelectricalcardioversionimprovesatrialthrombusdetectionandmayreduceassociatedthromboembolicevents AT seemuellergueler contrastenhancedtransesophagealechocardiographyinpatientswithatrialfibrillationreferredtoelectricalcardioversionimprovesatrialthrombusdetectionandmayreduceassociatedthromboembolicevents AT duttonraphael contrastenhancedtransesophagealechocardiographyinpatientswithatrialfibrillationreferredtoelectricalcardioversionimprovesatrialthrombusdetectionandmayreduceassociatedthromboembolicevents AT rieberjohannes contrastenhancedtransesophagealechocardiographyinpatientswithatrialfibrillationreferredtoelectricalcardioversionimprovesatrialthrombusdetectionandmayreduceassociatedthromboembolicevents AT kaabstefan contrastenhancedtransesophagealechocardiographyinpatientswithatrialfibrillationreferredtoelectricalcardioversionimprovesatrialthrombusdetectionandmayreduceassociatedthromboembolicevents AT sohnhaeyoung contrastenhancedtransesophagealechocardiographyinpatientswithatrialfibrillationreferredtoelectricalcardioversionimprovesatrialthrombusdetectionandmayreduceassociatedthromboembolicevents |